-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A1OcEwF44dFBdsGPTLSWjhLkS0Zp/lb1wrYfxq0xh42sqZpW/X+UC0cFNGuzcy+/ N2amsJFt3q523auUeRkZ3Q== 0001104659-08-045356.txt : 20080711 0001104659-08-045356.hdr.sgml : 20080711 20080711181757 ACCESSION NUMBER: 0001104659-08-045356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080709 FILED AS OF DATE: 20080711 DATE AS OF CHANGE: 20080711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINDER GREG W CENTRAL INDEX KEY: 0001239128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 08949718 BUSINESS ADDRESS: STREET 1: ABBOTT LABORATORIES STREET 2: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-6049 BUSINESS PHONE: 8479376100 4 1 a4.xml 4 X0303 4 2008-07-09 0 0000001800 ABBOTT LABORATORIES ABT 0001239128 LINDER GREG W 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Vice President Common shares without par value 2008-07-09 4 M 0 9330 45.4488 A 154766 D Common shares without par value 2008-07-09 4 F 0 8156 57.37 D 146610 D Common shares without par value 12628 I Profit Sharing Trust Option (right to buy) 45.4488 2008-07-09 4 M 0 9330 0 D 2004-02-09 2011-02-08 Common Shares 9330 2200 D Option (right to buy) 57.37 2008-07-09 4 A 0 8156 0 A 2009-01-10 2011-02-08 Common Shares 8156 8156 D Balance in the Abbott Laboratories Stock Retirement Trust as of July 8, 2008. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on February 8, 2008. John A. Berry, by power of attorney for Greg W. Linder 2008-07-11 -----END PRIVACY-ENHANCED MESSAGE-----